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SUMMARY
Aim: To determine the frequency of reporting and the
methodological quality of randomized controlled trials in the
Nigerian Journal of Ophthalmology (NJO) from 1993 – 2001.
Materials and methods: Back issues of NJO published from
1993 to 2001 were searched for reports of randomized
controlled trials. The quality of identified trials was assessed
using standard Cochrane methods.
Results: One out of 104 articles published in the 9 volumes of
NJO from 1993 – 2001 can be described as a randomized
controlled trial. Complete information regarding the method
of allocation concealment, masking of providers and recipients
of care, and masking of outcome assessors was not provided.
It was not clear whether all patients were followed-up for 6
months or 1 year, or whether there was a differential loss to
follow-up between the study groups.
Conclusions: Only one randomized controlled trial was
published in the Nigerian Journal of Ophthalmology between
1993-2001. Assessment of the methodological quality of the
reported trial was hampered by lack of complete information
on parameters used to assess trial quality in this study. 
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INTRODUCTION
A clinical trial is defined as a prospective study comparing
the effect and value of intervention(s) against a control in
human subjects.  Randomized controlled trials (RCTs) are1
generally regarded as the gold standard in scientific research
when considering questions of therapeutic efficacy.  While
evidence from case control studies and cohort studies can be
used to answer questions of efficacy, confounding factors are
usually a major cause of concern, especially if they are not
known or have not been measured. The process of
randomization in RCTs, if properly done, helps to control for
the effect of puzzling variables. It is, therefore, believed that
RCTs are likely to provide more reliable information than
other sources of evidence on the differential effects of
alternative forms of healthcare interventions.2
A poorly designed and conducted RCT, however, may
provide misleading information on the effects of a health
care intervention. Therefore, the methodological quality of
RCTs is important in determining the validity or reliability
of trial results. Several scales and checklists have been used
to assess the quality of trials,  but these scales and checklists 3
have not been shown to provide consistent and reliable
assessment of validity. In this study, we adopted a simple4 
approach, using parameters which address important
substantive threats to study validity.  Concealment of5
allocation helps to minimize selection bias (systematic
differences in comparison groups), while masking of patients
and providers of treatment helps to reduce performance bias
(systematic differences in care provided apart from the
intervention being evaluated). Masking of outcome assessors
helps to reduce detection bias (systematic differences in
outcome assessment). A complete follow-up or good account
of losses to follow-up helps to reduce attrition bias
(systematic differences in withdrawals from the trial). 
The practice of ophthalmology is evolving rapidly due
to the introduction of new interventions in the management
of ophthalmic diseases. A good example is the shift from
intracapsular cataract extraction to extracapsular cataract
extraction and more recently to small incision techniques
with phacoemulsification. Similarly, antimetabolites have
been introduced in some centres in the surgical management
of glaucoma when indicated. 
Ophthalmologists are often faced with the need to
choose between alternative forms of health care
interventions in the management of patients. Although
evidence from trials of interventions conducted elsewhere
and in different populations can inform these choices, there
is, however, usually some uncertainty regarding the
applicability of such interventions in patients drawn from
African populations. There is, therefore, a need to conduct
trials among African patients to test the efficacy and safety
of some of these new interventions, before they are generally
adopted. The Nigerian Journal of Ophthalmology (NJO) is the
official organ of the Ophthalmological Society of Nigeria and
a source of information regarding ophthalmic research
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conducted by ophthalmologists practising in Nigeria.
Ophthalmologists practising in Nigeria may therefore rely
on NJO as a source of information with respect to clinical
trials conducted in Nigeria. Therefore, a survey of NJO was
carried out from 1993-2001 to determine the frequency of
reporting and the methodological quality of randomized
controlled trials published therein. 
METHODS
Back issues of NJO from 1993 to 2001 were reviewed in order
to identify randomized controlled trials (RCTs); article titles,
summaries/abstracts, and methodologies of published
articles were manually searched using the following search
terms: clinical trial; controlled trial; randomization;
masking/blinding, or placebo. Methodological quality was
assessed according to methods set out in section six of the
Cochrane Reviewer's Handbook.  The following parameters5
were considered: concealment of allocation, masking of
providers and recipients of care, masking of outcome
assessors, and adequacy or comparability of follow-up rates
in treatment and control groups. 
Concealment of allocation was considered adequate if
allocation was by centralized randomization either by a
central office or pharmacy; the sequential administration of
pre-numbered or coded containers to enrolled participants,
serially numbered sealed opaque envelopes, or on-site
computer systems provided the computer file containing the
assignment is locked. Allocation based on alternation, case
records numbers, dates of birth, or day of the week was
considered inadequate, as they are likely to lead to selection
bias.   
RESULTS
Frequency of reporting of randomized controlled trials 
A total of 104 articles were published in 9 volumes of NJO
from 1993 to 2001 (table 1). Only one of these articles (0.96%)
can be described as a randomized controlled trial.6
Table 1. Total number of published articles in NJO (1993 to
2001)
 Year Vol Issue Articles RCTs
1993 2 1 18 0
1994 2 2 11  0
1995 3 2 12 0
1996 4 1 12 0
1997 5 1 15 0
1998 6 1 8 0
1999 7 1 10 1 
2000 8 1 7  0
2001 9 1 11 0
TOTAL 104 1
Participants in this trial comprised 32 patients diagnosed
as having pterygium (fleshy and vascular type). Patients
were randomized to receive bare sclera plus 5-fluorouracil
{50mg/ml} (20 patients and 28 eyes) or bare sclera technique
alone (12 patients and 16 eyes). Outcomes were recurrence
rate and complications. The intended period of follow-up
was not stated at the outset. 
Methodological quality of trial
Concealment of allocation: Method of allocation of patients to
 treatment groups was not stated.
Masking of providers and recipients: Not stated
Masking of outcome assessors: Not stated
Completeness of follow up: Not clear whether there were any
losses to follow up and whether all patients were followed
up for 6 months or one year.
DISCUSSION
The finding of only one randomized controlled trial (RCT)
among 104 published articles in 9 issues of the NJO from
1993 – 2001 seems to suggest the low priority given to this
type of study design by ophthalmologists involved in
research in Nigeria. For many obvious reasons, we cannot
directly compare the NJO with the British Journal of
Ophthalmology (BJO), but a quick electronic search of Medline
(Pubmed) showed that about 15% (98 out of 639) of articles
published in the BJO from 1993-2001 were indexed as clinical
trials. 
The present study cannot answer the question as to how
many RCTs relevant to ophthalmology are actually
conducted within Nigeria, or how many of these are
published in other journals outside Nigeria. However, a
qualitative study is underway to assess the knowledge and
attitude to RCTs among Nigerian ophthalmologists. This is
important given the role of RCTs in providing reliable
evidence to inform and direct practice. 
Assessment of the quality of the only identified trial was
difficult as the report of this trial did not include details of
how randomization was done, whether allocation of patients
to treatment or control groups was concealed or not, or
whether providers and recipients of treatment were masked.
Information on whether outcome assessment i.e. recurrence
rate and complications was masked or not was not stated.
Although it was stated that follow-up was between 6-12
months, it is unclear whether all the patients were followed-
up within that period.  
It is not certain if the lack of reporting of quality
parameters in the identified trial was due to the fact that they
were not considered in the design of the trial or whether they
were considered but not reported, because of journal
restrictions on the number of words or pages per article.
Good reporting of a trial facilitate the understand of
what was done in the trial, how it was done and how the
authors attempted to prevent bias. A standard for reporting
of trials has been developed and published, and is known7 
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as the Consolidated Standards of Reporting Trials
(CONSORT).  The CONSORT statement was designed to
ensure adequate reporting of randomised controlled trials by
listing over 20 items, including a flow chart describing the
participants' progress through the trial that should be
included in a report. The Nigerian Journal of Ophthalmology
should insist that all randomized trial authors should follow
CONSORT statement to ensure that their R CT trials provide
reliable information.  
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